Tower Research Capital LLC (TRC) - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 81 filers reported holding CUE BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q2 2024$14,113
+128.5%
11,381
+248.3%
0.00%
Q1 2024$6,177
-52.2%
3,268
-33.2%
0.00%
Q4 2023$12,923
+1.6%
4,895
-11.5%
0.00%
Q3 2023$12,714
+23.8%
5,528
+96.5%
0.00%
Q2 2023$10,267
+71.1%
2,813
-3.2%
0.00%
Q3 2022$6,000
-53.8%
2,906
-47.4%
0.00%
Q2 2022$13,000
-18.8%
5,522
+68.7%
0.00%
Q1 2022$16,000
-40.7%
3,273
+37.9%
0.00%
Q4 2021$27,000
-34.1%
2,373
-14.9%
0.00%
-100.0%
Q3 2021$41,000
-31.7%
2,787
-45.7%
0.00%
-50.0%
Q2 2021$60,000
+275.0%
5,131
+299.0%
0.00%
Q1 2021$16,000
-61.9%
1,286
-61.6%
0.00%
-100.0%
Q4 2020$42,000
+133.3%
3,349
+183.6%
0.00%
Q3 2020$18,000
-90.4%
1,181
-84.6%
0.00%
-100.0%
Q2 2020$188,000
+4600.0%
7,650
+1426.9%
0.01%
Q3 2019$4,000
-75.0%
501
-75.7%
0.00%
-100.0%
Q1 2019$16,000
-84.3%
2,065
-90.5%
0.00%
-85.7%
Q4 2018$102,000
+175.7%
21,641
+430.5%
0.01%
+133.3%
Q3 2018$37,000
+825.0%
4,079
+1136.1%
0.00%
Q2 2018$4,000
-33.3%
330
-20.1%
0.00%
-100.0%
Q1 2018$6,0004130.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Corriente Advisors, LLC 1,437,445$21,634,00010.97%
Prosight Management, LP 709,936$10,685,0005.08%
Voss Capital, LP 226,573$3,410,0001.94%
Robertson Stephens Wealth Management, LLC 484,000$7,284,0001.79%
Slate Path Capital LP 1,483,619$22,328,0001.27%
Nantahala Capital Management 2,342,216$35,250,0001.08%
SANDERS MORRIS HARRIS LLC 142,430$2,312,0000.63%
Rock Creek Group, LP 80,000$1,204,0000.62%
PRECEPT MANAGEMENT LLC 150,000$2,258,0000.55%
PA Capital LLC 46,850$705,0000.50%
View complete list of CUE BIOPHARMA INC shareholders